The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Synopsis
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleeping Pills (Prescription Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeping Pills (Prescription Drugs).
Report Scope
The Sleeping Pills (Prescription Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleeping Pills (Prescription Drugs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleeping Pills (Prescription Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
Segment by Type
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sleeping Pills (Prescription Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeping Pills (Prescription Drugs).
Report Scope
The Sleeping Pills (Prescription Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sleeping Pills (Prescription Drugs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleeping Pills (Prescription Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
Segment by Type
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sleeping Pills (Prescription Drugs) Market Overview
1.1 Product Overview and Scope of Sleeping Pills (Prescription Drugs)
1.2 Sleeping Pills (Prescription Drugs) Segment by Type
1.2.1 Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024-2030)
1.2.2 Zolpidem
1.2.3 Eszopiclone (Lunesta)
1.2.4 Ramelteon (Rozerem)
1.2.5 Ativan (lorazepam)
1.2.6 Adapin (doxepin)
1.3 Sleeping Pills (Prescription Drugs) Segment by Application
1.3.1 Global Sleeping Pills (Prescription Drugs) Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global Sleeping Pills (Prescription Drugs) Market Size Estimates and Forecasts
1.4.1 Global Sleeping Pills (Prescription Drugs) Revenue 2019-2030
1.4.2 Global Sleeping Pills (Prescription Drugs) Sales 2019-2030
1.4.3 Global Sleeping Pills (Prescription Drugs) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sleeping Pills (Prescription Drugs) Market Competition by Manufacturers
2.1 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sleeping Pills (Prescription Drugs) Average Price by Manufacturers (2019-2024)
2.4 Global Sleeping Pills (Prescription Drugs) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application
2.7 Sleeping Pills (Prescription Drugs) Market Competitive Situation and Trends
2.7.1 Sleeping Pills (Prescription Drugs) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sleeping Pills (Prescription Drugs) Players Market Share by Revenue
2.7.3 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sleeping Pills (Prescription Drugs) Retrospective Market Scenario by Region
3.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sleeping Pills (Prescription Drugs) Global Sleeping Pills (Prescription Drugs) Sales by Region: 2019-2030
3.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2019-2024
3.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2025-2030
3.3 Global Sleeping Pills (Prescription Drugs) Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2019-2030
3.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2019-2024
3.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2025-2030
3.4 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.4.1 North America Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.4.3 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.5.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.5.3 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.6.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.6.3 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.7.1 Latin America Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.7.3 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2019-2030)
4.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2019-2024)
4.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Type (2025-2030)
4.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2019-2030)
4.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2019-2030)
4.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2019-2024)
4.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2025-2030)
4.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2019-2030)
4.3 Global Sleeping Pills (Prescription Drugs) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2019-2030)
5.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2019-2024)
5.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Application (2025-2030)
5.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2019-2030)
5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2019-2030)
5.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2019-2024)
5.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2025-2030)
5.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2019-2030)
5.3 Global Sleeping Pills (Prescription Drugs) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Corporation Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Actellon Pharmaceuticals
6.6.1 Actellon Pharmaceuticals Corporation Information
6.6.2 Actellon Pharmaceuticals Description and Business Overview
6.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio
6.6.5 Actellon Pharmaceuticals Recent Developments/Updates
6.7 Allegiant Health
6.6.1 Allegiant Health Corporation Information
6.6.2 Allegiant Health Description and Business Overview
6.6.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio
6.7.5 Allegiant Health Recent Developments/Updates
6.8 Cayman Chemical
6.8.1 Cayman Chemical Corporation Information
6.8.2 Cayman Chemical Description and Business Overview
6.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio
6.8.5 Cayman Chemical Recent Developments/Updates
6.9 Ambitropin
6.9.1 Ambitropin Corporation Information
6.9.2 Ambitropin Description and Business Overview
6.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio
6.9.5 Ambitropin Recent Developments/Updates
6.10 Hayao
6.10.1 Hayao Corporation Information
6.10.2 Hayao Description and Business Overview
6.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio
6.10.5 Hayao Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis
7.2 Sleeping Pills (Prescription Drugs) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
7.4 Sleeping Pills (Prescription Drugs) Sales and Marketing
7.4.1 Sleeping Pills (Prescription Drugs) Sales Channels
7.4.2 Sleeping Pills (Prescription Drugs) Distributors
7.5 Sleeping Pills (Prescription Drugs) Customers
8 Sleeping Pills (Prescription Drugs) Market Dynamics
8.1 Sleeping Pills (Prescription Drugs) Industry Trends
8.2 Sleeping Pills (Prescription Drugs) Market Drivers
8.3 Sleeping Pills (Prescription Drugs) Market Challenges
8.4 Sleeping Pills (Prescription Drugs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
